| Sandoz Pharmaceuticals AG - Lenalidomid Sandoz 7.5 mg, Kapseln | | 67456 | | 03 | | Lenalidomid Sandoz 7.5 mg | | Kapseln | | L04AX04 | | Lenalidomide | | 05.05.2020 | | |
| | Composition | | lenalidomidum 7.5 mg, cellulosum microcristallinum, lactosum 99.7 mg, carmellosum natricum conexum corresp. natrium 0.266 mg, magnesii stearas, gelatina, E 171, E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Lenalidomidum | 7.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lenalidomidum | 7.5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Lactosum | 99.7 mg | | | Magnesii Stearas | | | | Pro Capsula | | | | Propylenglycol | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 003 | 21 | | | A | | Oui | | 014 | 21 | 726.28 | 806.30 | A | LS | Non | | 015 | 21 | | | A | | Oui | | 016 | 21 | | | A | | Oui |
|
|
